Mesoblast
MESO
68 hedge funds and large institutions have $49.2M invested in Mesoblast in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 10 closing their positions.
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
60% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 15
11% more funds holding
Funds holding: 61 → 68 (+7)
9% more call options, than puts
Call options by funds: $6.21M | Put options by funds: $5.69M
0.05% more ownership
Funds ownership: 0.26% → 0.31% (+0.05%)
18% less capital invested
Capital invested by funds: $59.9M → $49.2M (-$10.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$8.02M |
| 2 |
Goldman Sachs
New York
|
+$4.24M |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$2.49M |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$2.47M |
| 5 |
Morgan Stanley
New York
|
+$2.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$4.19M |
| 2 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$3.56M |
| 3 |
Citigroup
New York
|
-$1.23M |
| 4 |
OFA
Oaktree Fund Advisors
Los Angles,
California
|
-$949K |
| 5 |
Jane Street
New York
|
-$883K |
MESO Hedge Fund Activity: Q1 2025 in Review
68 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2025, worth a combined $49.2M — down 18% from $59.9M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MESO positions and 10 closed out — a net gain of 7 holders — while 24 added to existing stakes and 15 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $8.02M. The largest seller was Bank of America, cutting an estimated $4.19M.
- 68 institutional investors held Mesoblast (MESO) as of Q1 2025, up from 61 in Q4 2024.
- Funds reported $49.2M of Mesoblast stock for Q1 2025, down 18% quarter-over-quarter.
- 17 funds opened new Mesoblast positions in Q1 2025 and 10 closed out, a net change of +7 holders.
- The largest Mesoblast buyer in Q1 2025 was Citadel Advisors, an estimated $8.02M added.
- The largest Mesoblast seller in Q1 2025 was Bank of America, an estimated $4.19M sold.
Based on aggregated 13F filings for Q1 2025.